You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Immunol., 19 December 2024

Sec. Inflammation

Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1538819

Corrigendum: Pyroglutamyl aminopeptidase 1 is a potential molecular target toward diagnosing and treating inflammation

  • 1. The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China

  • 2. Department of Thoracic Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

Article metrics

View details

791

Views

245

Downloads

In the published article, there was an error in the Funding statement. The Funding statement for the Natural Science Foundation of Shandong Province (ZR2021QH212) is wrong. The correct statement is “Shandong Postdoctoral Science Foundation (SDCX-ZG-202203015). The correct Funding statement appears below.

“The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research received funding supporting from the Shandong Postdoctoral Science Foundation (SDCX-ZG-202203015) and the Key Research and Development Project of Shaanxi Province (2023-YBSF-292).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

pyroglutamyl aminopeptidase 1 (PGP-1), inflammation, biomarker, anti-inflammatory therapy, cancer

Citation

Jiang H, Gong Q and Zhang R (2024) Corrigendum: Pyroglutamyl aminopeptidase 1 is a potential molecular target toward diagnosing and treating inflammation. Front. Immunol. 15:1538819. doi: 10.3389/fimmu.2024.1538819

Received

03 December 2024

Accepted

04 December 2024

Published

19 December 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: Qiuyu Gong, ; Renshuai Zhang,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics